Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial

Launched by REGIONAL HOSPITAL OF SCRANTON · Aug 8, 2024

Keywords

ClinConnect Summary

The SAFE & FAST trial is a research study aimed at improving the safety and effectiveness of heart procedures that use the wrist for access, known as transradial approach (TRA). Specifically, the trial is looking to reduce the chances of complications like bleeding and blockage in the radial artery after these procedures. Researchers believe that by using a lower dose of a blood thinner called heparin, along with applying pressure to the wrist area, they can help patients recover faster and with fewer issues.

If you are an adult over 18 years old and are scheduled for a heart test that involves the wrist, you might be eligible to participate in this trial. Participants will be asked to provide written consent and will receive special care during the procedure. However, those on long-term blood thinners or needing larger catheters may not be able to join. If you decide to participate, you can expect close monitoring and support from the medical team throughout the trial to ensure your safety and comfort.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients referred for diagnostic transradial cardiac catheterization
• • 2. Age ≥ 18 years
• • 3. Ability to provide written informed consent
• Exclusion Criteria:
• • 1. Absence of written informed consent
• • 2. Patients on long-term systemic anticoagulation therapy for a different indication
• • 3. Patients requiring a heparin dose of greater than 50 units per kilogram before, during, or after the procedure for any reason.
• • 4. Patients requiring greater than 6 French catheter access